Market Capitalization of Balaxi Pharmaceuticals (BALAXI)
As of Sept. 18, 2026, Balaxi Pharmaceuticals (BALAXI) market capitalisation is ₹128.52 Cr ($14.28M), with 5.46 Cr shares outstanding at a current price of ₹23.55 on NSE, ranking 2928 out of 5367 companies by market cap in our screener. Balaxi Pharmaceuticals operates in the Healthcare sector and is classified as a Small Cap stock. View BALAXI 52-week performance for the annual high/low range and current price position.
Market Cap History of Balaxi Pharmaceuticals (Last 10 Years)
BALAXI market capitalisation from year-end NSE closing prices over the last 10 years. For live price, earnings and the complete company profile, see BALAXI share price.
End of Year Market Cap History — Balaxi Pharmaceuticals
BALAXI year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. Explore Balaxi Pharmaceuticals intrinsic price to estimate fundamental worth using multiple valuation models.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹128.52 Cr
$14.28M USD
|
₹23.55 | NSE | -12.36% |
| 2025 |
₹146.64 Cr
$16.29M USD
|
₹26.87 | NSE | -62.84% |
| 2024 |
₹394.62 Cr
$43.85M USD
|
₹72.31 | NSE | -16.36% |
| 2023 |
₹471.79 Cr
$52.42M USD
|
₹86.45 | NSE | -28.82% |
| 2022 |
₹662.79 Cr
$73.64M USD
|
₹121.45 | NSE | +18.37% |
| 2021 |
₹559.92 Cr
$62.21M USD
|
₹102.60 | NSE | -21.08% |
| 2020 |
₹709.45 Cr
$78.83M USD
|
₹130.00 | NSE | +700.00% |
| 2019 |
₹88.68 Cr
$9.85M USD
|
₹16.25 | NSE | +185.09% |
| 2018 |
₹31.11 Cr
$3.46M USD
|
₹5.70 | NSE | +93.22% |
| 2017 |
₹16.10 Cr
$1.79M USD
|
₹2.95 | NSE | -13.24% |
| 2016 |
₹18.55 Cr
$2.06M USD
|
₹3.40 | NSE | -33.98% |
| 2015 |
₹28.11 Cr
$3.12M USD
|
₹5.15 | NSE | - |